1. Introduction {#s0005}
===============

Colon carcinoma is a common type of malignant tumor of the alimentary system. In recent years, as the daily diet of many individuals has changed, the incidence and mortality associated with colon carcinoma have increased worldwide. In America, the incidence of colon carcinoma has increased dramatically, making this cancer type the third highest among common malignant tumors ([@b0050]). Since the onset of colon carcinoma is insidious with ambiguous symptoms, the opportunity for early treatment is often missed, and most patients have been in middle or late stages when they are diagnosed ([@b0065]). Therefore, the early diagnosis of colon carcinoma is particularly important for the management of this disease.

There are several diagnostic methods for detection of colorectal cancer. Firstly, fecal occult blood tests (FOBTs), a common method used to detect colon carcinoma, can be used to identify fecal occult blood which is one of the symptoms of early-stage colon carcinoma. Secondly, endoscopy performed generally by a fibrocolonoscope or electronic colonoscope, is the most effective means to identify and diagnose colon carcinoma and is also the primary method for early-stage diagnosis with high accuracy. This method can be used to directly observe colonic lesions and perform qualitative biopsy ([@b0090]). Thirdly, tumor marker test is common method to diagnose all tumors. To date, carcinoembryonic antigen (CEA) is broadly used as a cancer marker in the clinical setting. Additionally, some carbohydrate antigens are evaluated as indexes of early-stage colon carcinoma; these antigens include CA199, CA242, and CA50. These indexes alone or their combinations are helpful for the early diagnosis of colon carcinoma in the clinical setting. Fourthly, gene-based diagnosis is also adopted for detection of colon carcinoma which is a multigenic disease involving several carcinogenic steps. The occurrence and development of colon carcinoma involve changes in multiple cancer-associated genes. Mutations in genes such as APC, KRAS, p53, and DCC can occur during the process of carcinogenesis and metastasis ([@b0070]). Finally, enzymes such as telomerase (TLMA) ([@b0030]) and cyclooxygenase 2 can be used as markers of colon carcinoma.

Serum tumor markers usually refer to the substances in blood produced and released by tumor tissues. Analysis of tumor markers has been broadly applied in the clinical setting; however, this method has several limitations ([@b0040]). The optimal serum tumor markers are sensitive and specific. However, among dozens of serum tumor markers currently used for detection of colon carcinoma, most are not sensitive or specific ([@b0060]). Thus, analysis of the sensitivity and specificity of tumor markers is clinically meaningful. In this report, we present a combined mathematical and bioinformatics analysis of the specificity of a few common tumor markers.

2. Materials and methods {#s0010}
========================

2.1. General data {#s0015}
-----------------

Group with Colon Carcinoma: A total of 100 patients who visited Affiliated Cancer Hospital of Zhengzhou University from January 2013 to December 2013 and underwent surgery for colon carcinoma, were enrolled in this study, including 56 men and 44 women (average age: 59.0 years, range: 25--82 years),. According to the World Health Organization (WHO) standards on pathological types and degrees of differentiation, there were 72 cases of colorectal tubular adenocarcinoma, 17 cases of mucinous adenocarcinoma, and 11 cases of papillary-tubular adenocarcinoma; and there were 12 cases exhibiting poorly differentiated tumors, 79 cases exhibiting moderately differentiated tumors, and nine cases exhibiting well-differentiated tumors. All patients were confirmed by operation and pathology, and imaging and surgical exploration demonstrated that no patients showed metastasis to other tissues or organs.

Control Group with Benign Tumors: Fifty patients who were admitted to Affiliated Cancer Hospital of Zhengzhou University within the same time period, including 21 men and 29 women (average age: 52.5 years, range: 32--80 years) were also enrolled in this study. There were 20 cases of colitis, 16 cases of polyposis coli, nine cases of colorectal tubular adenoma, and five cases of rectal-villous-papillary epithelioma. All diagnoses were proven by clinical analysis, endoscopy, and pathological examination.

All patients agreed to participate in the study and provided written informed consent.

2.2. Clinical examination of tumor markers {#s0020}
------------------------------------------

All patients were phlebotomized after fasting, and 2 mL isolated serum was cryopreserved at −80 °C, being prepared for centralized serum examination. The levels of CEA, neuron-specific enolase (NSE), heat-shock protein 60 (HSP60), CYFRA21-I, tissue plasminogen activator (TPA), alpha-feto protein (AFP), CA199, CA242, CA724, CA125, CA153, and UGT1A8 in the serum were measured by enzyme-linked immunosorbent assays and a COBAS 6000 automatic electrochemiluminescence immunoassay analyzer (Roche, Switzerland).

2.3. Index screening by Logistic regression {#s2000}
-------------------------------------------

Taking 12 indexes as covariate and pathological diagnosis results as dependent variable, Logistic regression analysis was used to screen indexes for benign and malignant tumor differentiation.

2.4. Screening indexes using Bhattacharyya distance {#s0025}
---------------------------------------------------

Bhattacharyya distance was used to sequence and screen the indexes. Bhattacharyya distances show the upper bounds of the minimum error rate of Bayes in sample normal distributions. This method is linked to error rate, and it can theoretically gain the advantageous features of classifications but hardly obtain analytic solutions. For selection of features, multidimensional and low-dimensional data were both feasible. The definition of the Bhattacharyya distance of each index between colon carcinoma samples and normal samples is shown in Eq. [(1)](#e0005){ref-type="disp-formula"} ([@b0080]). Larger Bhattacharyya distances were associated with better classified effects.

In this formula, μi+ and σi+ are the mean and variance of colon carcinoma samples, respectively, and μi− and σi− are the mean and variance of the sample in the control group, respectively. In this study, the calculations for the Bhattacharyya distances were carried out using MATLAB.

2.5. Accuracy validation by SVM {#s0030}
-------------------------------

The specificity of indexes screened by Bhattacharyya distances was validated using SVMs, and the establishment, training, and validation of SVM models were all implemented based on the MATLAB tools program ([@b0005]).

First, 150 patients were normalized. The malignant regions of samples were marked as 1, and the benign regions were marked as 0. Eighty out of 100 patients with malignant tumors and 40 out of 50 patients with benign tumors were chosen, yielding a matrix of 120 × 12. The samples were input into the SVM for training. During the training, penalty parameter C and nuclear parameter γ were gradually optimized to achieve better results. The remaining 20 patients with malignant tumors and 10 patients with benign tumors were evaluated as the testing samples and input into the SVM network after training; the corresponding results (1 or 0) were obtained. The accuracy could be determined by comparison with the objective.

3. Results {#s0035}
==========

3.1. Results of serum content analysis {#s0040}
--------------------------------------

The results from tumor marker analyses for the 150 samples in the two groups are listed in [Table 1](#t0005){ref-type="table"}. The 12 indexes were CEA, NSE, HSP60, CYFRA21-I, TPA, AFP, CA199, CA242, CA724, CA125, CA153, and UGT1A8.

3.2. Logistic regression analysis of each index {#s2050}
-----------------------------------------------

Through Logistic regression analysis, CEA, CA199 and HSP60 were finally screened out, and the corresponding *P* values were 0.000, 0.000 and 0.008 respectively ([Table 2](#t2000){ref-type="table"}).

3.3. Bhattacharyya distance of each index {#s0045}
-----------------------------------------

The Bhattacharyya distance of each index was calculated according to Eq. [(1)](#e0005){ref-type="disp-formula"}. The results are shown in [Table 3](#t0010){ref-type="table"}. The Bhattacharyya distances of NSE, CEA, CA724, and AFP were larger, followed by those of CYFRA21-I and CA125.

3.4. Establishment of different diagnosis models by SVM {#s0050}
-------------------------------------------------------

Based on the 12 indexes and the six indexes screened out by Logistic regression and Bhattacharyya distance respectively, two SVM models were established. 30 test samples were input into SVM models to perform stimulation, and results are shown in [Figure 1](#f0005){ref-type="fig"}, [Figure 2](#f0010){ref-type="fig"}. Results show that the accuracy, sensitivity and specificity of the SVM model based on 12 indexes were 73.3%, 75.0% and 70.0%, and those of the SVM model based on six screened-out indexes were 90.0%, 85.0%, and 100.0%.

4. Discussion {#s0055}
=============

There are many methods for analyzing the specificity of certain features. The most common method is the measurement of distance. Statistical pattern recognition states that as the distance between two categories becomes larger, the classification becomes easier, and the error rate becomes lower. Distance measure is also called class separability criteria or scatter criteria. The study of class separability in statistical pattern recognition is relatively deep. Distance is an important concept in statistical pattern recognition and is often analyzed using Euclidean distances, Mahalanobis distances, and Bhattacharyya distances ([@b0055]). Euclidean distances and Mahalanobis distances are defined in terms of space, whereas Bhattacharyya distances are defined in terms of probability. With regard to selection of features, subsets that can result in the largest classifying distance and the lowest error rate should be selected. The Bhattacharyya distance is usually applied to the feature analysis of gene expression profiles and is applicable to both multidimensional and low-dimensional data.

Serum tumor markers were screened by Logistic regression and Bhattacharyya distance, and six indexes were screened out (CEA, CA199, HSP60, NSE, CA724, AFP), which was consistent with a few previous studies. Several reports have demonstrated that CEA and CA724 are of high value in the diagnosis of colon cancer ([@b0025]). A study by [@b0075] found that the serum CEA content in patients with colon cancer increased markedly, with a positive rate of 32.26%. Some studies have also reported that when CEA is used to diagnose alimentary canal neoplasms, colorectal cancer exhibits the highest positive rate ([@b0045]). [@b0010] demonstrated that the sensitivity of AFP, NSE, CEA, and CA125 is 55.8% when these indexes are combined to detect gastric cancer and colon cancer. In addition, AFP is now recognized as the tumor marker with the highest specificity in primary liver cancer. However, 30--40% of samples are negative for APF ([@b0035]). A study by [@b0015] showed that AFP is statistically meaningless in the diagnosis of colon cancer. Notably, however, nonspecific serum tumor markers are of certain clinical value for diagnosis, assessment of lesion range and degree, evaluation of surgical outcomes, and examination of metastasis and postoperative recurrence in patients with colon carcinoma ([@b0085]).

From the results of our study, we concluded that when 12 indexes were combined to establish an SVM model, the accuracy was 73.33%, which was not optimal. However, when six indexes were combined to establish the SVM model, the accuracy was 90%. These data indicated that if too many indexes were used, the effective indexes could be influenced by the redundant indexes, thus decreasing the accuracy. A study by [@b0020] also found that when a single index was used to detect cancer, the difference between the indexes was not statistically significant. However, when five indexes, including CEA, CA199, CA724, and others were combined to detect cancer, the specificity and sensitivity were dramatically improved. Thus, these findings demonstrated that fewer indexes do not necessarily indicate better results but may lead to instability and unreliability of the results.$$B_{i} = \frac{1}{4}\frac{{(\mu_{i +} - \mu_{i -})}^{2}}{(\delta_{i +}^{2} + \delta_{i -}^{2})} + \frac{1}{2}\ln\left( \frac{\delta_{i +}^{2} + \delta_{i -}^{2}}{2\delta_{i +}\delta_{i -}} \right)$$

5. Conclusion {#s0060}
=============

High accuracy can't be achieved using too many tumor marker indexes. The application of Bhattacharyya distance can effectively screen out indexes with high specificity, and the combination of specific indexes can be used to establish an SVM diagnosis model with high accuracy. However, it is not necessarily good to use fewer indexes. The number of indexes should be controlled properly to avoid occasionality of the results.
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###### 

Analysis of 12 serum markers in the two groups (means ± standard deviations).

  Indexes groups   Colon cancer group        Control group
  ---------------- ------------------------- -------------------------
  CEA              29.31 ± 8.31 (ng/mL)      4.28 ± 1.39 (ng/mL)
  NSE              11.76 ± 2.33 (ng/mL)      2.45 ± 1.01 (ng/mL)
  HSP60            587.29 ± 477.44 (pg/mL)   201.45 ± 120.97 (pg/mL)
  CYFRA21-I        8.75 ± 2.22 (ng/mL)       1.98 ± 1.04 (ng/mL)
  TPA              0.87 ± 1.25 (U/mL)        0.081 ± 0.54 (U/mL)
  AFP              17.68 ± 5.15 (ng/mL)      2.78 ± 0.98 (ng/mL)
  CA199            52.03 ± 38.34 (U/mL)      24.03 ± 12.22 (U/mL)
  CA242            18.55 ± 10.09 (U/mL)      5.06 ± 1.47 (U/mL)
  CA724            5.87 ± 1.25 (U/mL)        1.06 ± 0.77 (U/mL)
  CA125            43.05 ± 9.73 (U/mL)       10.31 ± 7.65 (U/mL)
  CA153            21.40 ± k8.63 (U/mL)      15.14 ± 2.83 (U/mL)
  UGT1A8           8.52 ± 2.03 (ng/mL)       34.6 ± 12.16 (ng/mL)

###### 

Variables in Logistic regression equation.

                                                     B       S.E      Wals     df      Sig.    Exp (B)
  ----------------------------------------- -------- ------- -------- -------- ------- ------- ---------
  Step 1[a](#tblfn1){ref-type="table-fn"}   CA199    1.839   0.420    19.158   1       0.000   6.291
  Constant                                  0.024    0.220   0.012    1        0.913   1.024   
                                                                                               
  Step 2[b](#tblfn2){ref-type="table-fn"}   CEA      1.806   0.450    16.138   1       0.000   6.086
  CA199                                     1.922    0.447   18.508   1        0.000   6.834   
  Constant                                  −0.640   0.283   5.102    1        0.024   0.527   
                                                                                               
  Step 3[c](#tblfn3){ref-type="table-fn"}   CEA      1.721   0.462    13.911   1       0.000   5.592
  HSP60                                     1.252    0.472   7.044    1        0.008   3.496   
  CA199                                     1.920    0.459   17.502   1        0.000   6.823   
  Constant                                  −0.996   0.325   9.371    1        0.002   0.369   

Variable(s) entered on step 1: CA199.

Variable(s) entered on step 2:CEA.

Variable(s) entered on step 3: HSP60.

###### 

Bhattacharyya distances of tumor markers in the two groups.

  Index                    CEA      NSE      HSP60    CYFRA21-I   TPA      AFP      CA 199   CA242    CA724    CA125    CA153    UGT1A8
  ------------------------ -------- -------- -------- ----------- -------- -------- -------- -------- -------- -------- -------- --------
  Bhattacharyya Distance   3.4608   4.2107   1.2176   2.7314      0.9357   3.2135   1.0877   1.7578   3.4332   2.4567   1.0739   2.3742
